A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.

Autor: van Asten F; Department of Ophthalmology, Radboud University Medical Center, Nijmegen, The Netherlands., Evers-Birkenkamp KU, van Lith-Verhoeven JJ, de Jong-Hesse Y, Hoppenreijs VP, Hommersom RF, Scholten AM, Hoyng CB, Klaver JH

Publikováno v: Acta ophthalmologica [Acta Ophthalmol] 2015 Mar; Vol. 93 (2), pp. 126-33. Date of Electronic Publication: 2014 Dec 09.